Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or South Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to South Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. South Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

John Wells (NPI 1841289154)

Field	Value
Entity Type	Individual
Organization	John Wells
Address	124 Sunset Court
City	West Columbia
State	SC
ZIP	29169
Taxonomy	Ophthalmology Physician
NPI Enumerated	October 19, 2005

Payer Source	Total Paid
Medicare	$3.9M
Medicaid	$0

Key Findings

This provider’s Medicare business is the sole payer mix on file: Total Medicare revenue is $3.9M and there is no Medicaid billing on file, so the practice operates effectively as a single‑payer (Medicare) entity in the available datasets. That concentration of payer exposure limits Medicaid-based comparators and suggests analyses should focus on Medicare utilization trends and reimbursement drivers.

Revenue is highly concentrated in a small set of drug-injection codes: the precomputed top 3 Medicare codes by revenue account for 72.1% of this provider's total Medicare revenue, with J0178 at 42.7%, J2777 at 15.5%, and J2778 at 13.9%. This concentration indicates that a large majority of the provider’s Medicare dollars come from a narrow set of intravitreal biologic therapies rather than broad E&M or surgical mixes.

The CPT/HCPCS mix points to a retina-focused, injection-centric ophthalmology practice: the top codes are J0178 (aflibercept), J2777 (faricimab), and J2778 (ranibizumab), all intravitreal injection drugs used to treat macular and retinal diseases. High volumes of these therapeutics, together with standalone injection procedure billing (67028), are consistent with a clinic model that schedules frequent follow-up injection visits and drug administrations rather than one focused primarily on general ophthalmic office consults or elective surgery.

Competitive standing on the principal drug codes shows strong but not dominant national placement: J0178 ranks #329 of 3204 providers nationally (90th percentile; typical, unremarkable volume for this code), J2777 ranks #470 of 2039 (77th percentile; typical, unremarkable volume for this code), and J2778 ranks #110 of 1208 (91th percentile; typical, unremarkable volume for this code). These ranks indicate the provider is a solid, above‑median user of intravitreal biologics compared with national peers, but not an outlier leader across those drug classes.

Non-drug procedural and diagnostic codes reveal very high throughput for retinal imaging and follow-up visits: 92134 has 3.1K claims and ranks #356 of 26868 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code), and 92012 has 1.3K claims and ranks #249 of 17177 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code). This combination of extreme imaging volume plus frequent injection drug claims suggests a high-volume retina clinic with heavy reliance on imaging to guide ongoing intravitreal therapy.

The provider also reports a notable share of revenue from unclassified drug billing: J3490 generates $374.5K (9.5% of Medicare revenue) and ranks #324 of 2838 providers nationally (89th percentile; typical, unremarkable volume for this code). The sizable dollar contribution from J3490 may reflect miscellaneous or non-standard drug items billed under an unclassified code and warrants closer review when reconciling drug-level reimbursement and inventory.

Standalone injection procedure billing further emphasizes an injection-driven workflow: 67028 accounts for $196.9K (5.0% of Medicare revenue) with 2.2K claims and ranks #316 of 4255 providers nationally (93th percentile; notably above typical national volume for this code). The combination of high procedure counts and high drug-dollar concentration reinforces that office-based intravitreal injections are a core revenue driver for this provider.

This NPI has long tenure in the Medicare program (NPI enumerated 2005-10-19 (~21 years ago)), which, combined with the concentrated drug and high imaging volumes, is consistent with an established retina practice that has scaled recurring treatment workflows over many years. Analysts evaluating competitive dynamics or capacity should treat this provider as an experienced, injection-focused ophthalmology practice with Medicare-centered revenue exposure and minimal to no Medicaid footprint in available records.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

15 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,480	$680	$1.7M
J2777	Injection, faricimab‑svoa, 0.1 mg	21,840	$30	$611.5K
J2778	Injection, ranibizumab, 0.1 mg	3,070	$180	$545.6K
J3490	Unclassified drugs	200	$1,850	$374.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,160	$90	$196.9K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	850	$220	$186.2K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	860	$120	$101.7K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,110	$30	$87.1K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	1,320	$60	$83K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	370	$80	$29.2K

Showing 1–10 of 15

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. South Carolina Distribution

John Wells — 3 of 15 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — South Carolina

Full comparison — all codes billed, vs. state median

15 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	12	50	970	$690	$1.1M
J2777	12	40	15,960	$30	$594.7K
J2778	7	30	1,440	$180	$337.4K
Q5128	10	10	1,150	$220	$273.3K
J2781	6	20	720	$120	$128K
67028	10	50	1,140	$90	$110.3K
J3490	5	50	70	$510	$57.7K
67042	24	30	20	$1,150	$32.3K
J9035	29	40	200	$50	$26.1K
92014	161	540	160	$80	$24.3K

Showing 1–10 of 15

Related Providers

Other providers that share a Tax Identification Number (TIN) with John Wells, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Prisma Health University Medical Group	SC	Family Medicine Physician	$0	$171.7M
Prisma Health Medical Group-midlands	SC	Multi-Specialty Clinic/Center	$0	$77.6M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$74.6M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$68.3M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$28.1M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$11.8M
Palmetto Retina Center LLC	SC	Ophthalmology Physician	$0	$10.6M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$7.4M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$6.9M
Prisma Health Tuomey	SC	Emergency Medicine Physician	$0	$6.8M

Nearby Providers

Other providers in the same ZIP code as John Wells, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Palmetto Infusion Services LLC	SC	Infusion Therapy Clinic/Center	$0	$93.6M
Lexington Health Inc	SC	General Acute Care Hospital	$0	$27.4M
Lexington County Health Services District Inc	SC	General Acute Care Hospital	$0	$19.2M
United Cerebral Palsy Of South Carolina, Inc	SC	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$15.7M
Lexington Health Inc	SC	Emergency Medicine Physician	$0	$4.2M
Karen Park Family Dentistry, P.A.	SC	Dentist	$0	$4.2M
Lexington County Health Serv	SC	General Acute Care Hospital	$0	$4M
John Payne	SC	Ophthalmology Physician	$4M	$0
Steven Madden	SC	Hematology & Oncology Physician	$4M	$0
Lexington Treatment Specialists LLC	SC	Methadone Clinic	$76.7K	$3.6M

John Wells — Billing Profile & Reimbursement Data

Sign up for John Wells — Billing Profile & Reimbursement Data policy alerts

John Wells — Billing Profile & Reimbursement Data

Sign up for John Wells — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References